PBCRF(PBCRF)
PBCRF
No analyst ratings available
No analyst price targets available for PBCRF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $118.27T | $127.92T | $138.86T |
| Low | $115.22T | $123.37T | $134.57T |
| High | $120.53T | $133.90T | $143.51T |
| EBITDA Avg | $78.02T | $85.29T | $93.78T |
| Low | $75.00T | $82.00T | $90.16T |
| High | $81.29T | $88.87T | $97.71T |
| EBIT Avg | $75.10T | $82.05T | $90.21T |
| Low | $72.09T | $78.76T | $86.59T |
| High | $78.37T | $85.63T | $94.14T |
| Net Income Avg | $60.61T | $66.23T | $72.81T |
| Low | $58.18T | $63.57T | $69.89T |
| High | $63.26T | $69.11T | $75.99T |
| EPS Avg | $491.70 | $537.22 | $590.64 |
| Low | $471.98 | $515.68 | $566.95 |
| High | $513.14 | $560.65 | $616.39 |
| Analysts (Rev / EPS) | 20 / 1 | 21 / 1 | 17 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $29.50T | $30.46T | $30.91T | $31.61T |
| Low | $29.50T | $30.46T | $30.91T | $31.61T |
| High | $29.50T | $30.46T | $30.91T | $31.61T |
| EBITDA Avg | $720.58B | $738.39B | $756.15B | $774.22B |
| Low | $720.58B | $738.39B | $756.15B | $774.22B |
| High | $720.58B | $738.39B | $756.15B | $774.22B |
| EBIT Avg | $1.07B | $1.08B | $1.15B | $1.16B |
| Low | $1.07B | $1.08B | $1.15B | $1.16B |
| High | $1.07B | $1.08B | $1.15B | $1.16B |
| Net Income Avg | $866M | $872M | $926M | $938M |
| Low | $866M | $872M | $926M | $938M |
| High | $866M | $872M | $926M | $938M |
| EPS Avg | $125.86 | $126.71 | $134.56 | $136.31 |
| Low | $125.86 | $126.71 | $134.56 | $136.31 |
| High | $125.86 | $126.71 | $134.56 | $136.31 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |